Cantor Fitzgerald Comments on PTC Therapeutics, Inc.’s FY2024 Earnings (NASDAQ:PTCT)
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Cantor Fitzgerald dropped their FY2024 EPS estimates for PTC Therapeutics in a research report issued to clients and investors on Monday, July 1st. Cantor Fitzgerald analyst K. Kluska now forecasts that the biopharmaceutical company will post earnings per share of ($4.72) for the year, down […]
More Stories
Western Alliance Bancorporation (NYSE:WAL) Price Target Increased to $92.00 by Analysts at Wells Fargo & Company
Western Alliance Bancorporation (NYSE:WAL – Free Report) had its price objective upped by Wells Fargo & Company from $85.00 to...
Western Alliance Bancorporation (NYSE:WAL) Price Target Increased to $92.00 by Analysts at Wells Fargo & Company
Western Alliance Bancorporation (NYSE:WAL – Free Report) had its price objective upped by Wells Fargo & Company from $85.00 to...
Visa (NYSE:V) PT Raised to $310.00
Visa (NYSE:V – Get Free Report) had its price objective boosted by research analysts at BMO Capital Markets from $300.00...
Visa (NYSE:V) PT Raised to $310.00
Visa (NYSE:V – Get Free Report) had its price objective boosted by research analysts at BMO Capital Markets from $300.00...
Barclays Trims Valero Energy (NYSE:VLO) Target Price to $146.00
Valero Energy (NYSE:VLO – Free Report) had its price target trimmed by Barclays from $165.00 to $146.00 in a research...
Barclays Trims Valero Energy (NYSE:VLO) Target Price to $146.00
Valero Energy (NYSE:VLO – Free Report) had its price target trimmed by Barclays from $165.00 to $146.00 in a research...